Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000700880 | SCV000829656 | benign | Adams-Oliver syndrome 5 | 2025-01-28 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000769608 | SCV000901005 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2017-09-26 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000700880 | SCV002553961 | uncertain significance | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270970 | SCV002553962 | uncertain significance | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000769608 | SCV005456597 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2024-06-27 | criteria provided, single submitter | clinical testing | The p.V413M variant (also known as c.1237G>A), located in coding exon 7 of the NOTCH1 gene, results from a G to A substitution at nucleotide position 1237. The valine at codon 413 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. |